Holen Sie sich die Stockscreener-App
191.83
0.77%
-1.082
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$192.91
Offen:
$194
24-Stunden-Volumen:
217.34K
Relative Volume:
0.11
Marktkapitalisierung:
$28.97B
Einnahmen:
$4.39B
Nettoeinkommen (Verlust:
$853.00M
KGV:
34.82
EPS:
5.5097
Netto-Cashflow:
$556.00M
1W Leistung:
-1.19%
1M Leistung:
+0.72%
6M Leistung:
+63.87%
1J Leistung:
+89.31%
1-Tages-Spanne:
$187.44
$194.50
1-Wochen-Bereich:
$186.64
$196.04
52-Wochen-Spanne:
$88.00
$207.00
Illumina Inc Stock (ILMN) Company Profile
Firmenname
Illumina Inc
Sektor
Branche
Telefon
(858) 202-4500
Adresse
5200 ILLUMINA WAY, SAN DIEGO, CA
Compare ILMN vs TMO, DHR, NTRA, IDXX, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ILMN
Illumina Inc
|
191.84 | 29.13B | 4.39B | 853.00M | 556.00M | 5.5097 |
TMO
Thermo Fisher Scientific Inc
|
601.14 | 222.96B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
204.84 | 144.67B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
312.69 | 45.54B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
566.99 | 44.95B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.80 | 41.87B | 7.23B | 1.41B | 1.09B | 4.979 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Bestätigt | Citigroup | Neutral |
| 2025-02-28 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-02-10 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-11-12 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-08-28 | Hochstufung | Argus | Hold → Buy |
| 2024-08-16 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-01-16 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-01-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-11-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Eingeleitet | Bernstein | Underperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
| 2023-01-25 | Herabstufung | Argus | Buy → Hold |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Perform |
| 2022-12-12 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-04 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Hochstufung | Stifel | Hold → Buy |
| 2022-01-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Underweight |
| 2020-12-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-10-13 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2020-09-21 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-24 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-10-25 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Illumina Inc Aktie (ILMN) Neueste Nachrichten
Illumina stock steadies as $300 million note deal follows earnings beat - AD HOC NEWS
Illumina, Inc. (ILMN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Illumina Announces $300 Million 4.95% Notes Offering Maturing in 2029 - Kalkine Media
Form 8K Illumina Inc For: 12 August By Investing.com - Investing.com Canada
Illumina announces $300 million note offering to refinance existing debt By Investing.com - Investing.com India
Illumina announces $300 million note offering to refinance existing debt - Investing.com
Illumina prices $300M of 4.950% notes due 2029 to refinance Sept. 2026 debt - TradingView
Illumina (ILMN) plans $300M 4.950% notes due 2029 to refinance 2026 debt - Stock Titan
32,967 Shares in Illumina, Inc. $ILMN Bought by Insight Wealth Strategies LLC - MarketBeat
Illumina (ILMN) Is Up 5.7% After Raising 2026 Revenue Guidance and Q3 Outlook - Sahm
Illumina Building Clinical Momentum Amid Fading Competition, RBC Capital Markets Says - marketscreener.com
The Zacks Analyst Blog Highlights Illumina, Qnity Electronics and nVent Electric - Yahoo Finance
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Illumina Stock Is Up 40% Since January. Should You Still Ride the Wave in 2026? - TIKR.com
Illumina, Inc. (ILMN) Stock Analysis: Navigating Potential Upside In Genomic Innovation - directorstalkinterviews.com
Assenagon Asset Management S.A. Grows Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina Inc (ILMN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
ETFs Investing in Illumina, Inc. Stocks - TradingView
Independent Director Keith Meister Sold A Bunch Of Shares In Illumina - simplywall.st
Empowered Funds LLC Increases Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
Equity awards tie Illumina, Inc. (ILMN) CCO pay to EPS and TSR - Stock Titan
Illumina agrees mutual-release settlement to dismiss Icahn Partners litigation; dismissal hearing set Nov 2, 2026 - TradingView
Price to earnings forward of Illumina, Inc. – DUS:ILU - TradingView
What Makes Illumina (ILMN) a New Strong Buy Stock - Yahoo Finance
Illumina, Inc. $ILMN Stock Holdings Lessened by Westmount Partners LLC - MarketBeat
ILMN|Illumina Inc|Price:191.209|Chg%:+3.249 - TradingKey
Keith Meister Sells 283,269 Shares of Illumina (NASDAQ:ILMN) Stock - MarketBeat
A Look at Illumina Inc (ILMN) After 3.1% Decline -- GF Value $13 - GuruFocus
Illumina Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Illumina (ILMN) sees Corvex-advised funds sell 741,127 common shares - Stock Titan
Here's How Much $1000 Invested In Illumina 20 Years Ago Would Be Worth Today - Sahm
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Illumina (ILMN) Rose on Strong Clinical Momentum - Yahoo Finance
Illumina, Inc. $ILMN Shares Sold by Bank of America Corp DE - MarketBeat
Pacer Advisors Inc. Grows Stock Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina Inc. stock underperforms Monday when compared to competitors - MarketWatch
Illumina, Inc. (ILMN) legal chief sells 615 shares in planned trade - Stock Titan
The Manufacturers Life Insurance Company Raises Holdings in Illumina, Inc. $ILMN - MarketBeat
Illumina, Inc. (ILMN) Stock Analysis: Navigating Growth Amidst Market Challenges - directorstalkinterviews.com
Royal Bank of Canada Has $52.90 Million Stake in Illumina, Inc. $ILMN - MarketBeat
Why Illumina (ILMN) Is Up 5.7% After Raising 2026 Revenue Outlook On Clinical Sequencing - Yahoo Finance
Illumina, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:ILMN) 2026-07-31 - Seeking Alpha
Illumina Inc : RBC Raises Target Price to $23 - Moomoo
Illumina Earnings: Strong Instrument Sales and Growing AI Opportunities Boost 2026 Outlook - Morningstar
Illumina Looks Likely To Benefit From AI Initiatives in Life Sciences - Morningstar
Illumina, Inc. Provides Earnings Guidance for the Fiscal Year 2026 - marketscreener.com
Illumina (ILMN) Stock Rises on Q2 2026 Earnings - Quiver Quantitative
Illumina: Q2 Earnings Snapshot - ktvb.com
Illumina (ILMN) insider schedules Rule 144 sale and details 10b5-1 trades - Stock Titan
Illumina, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 28, 2026 - marketscreener.com
Finanzdaten der Illumina Inc-Aktie (ILMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):